Videos From Series
In this webinar, learn how the new EyeArt® Autonomous AI system is transforming the management of Diabetic Retinopathy (DR):
- Detection of More than Mild and Vision Threatening DR with the EyeArt Autonomous AI System
- Results from the EyeArt System Prospective, Multi-Center Pivotal Clinical Trial
- A University Health System's Vision in Using AI Technology to Manage Screening and Treatment of DR and Other Eye Diseases
Speakers:
SriniVas R. Sadda, MD,
President and Chief Scientific Officer, Doheny Eye Institute Chair of Ophthalmology, UCLA Geffen School of Medicine
Jennifer I. Lim, MD,
Vice Chair in Ophthalmology and Director of the Retina Service, University of Illinois at Chicago
Jeffrey D. Henderer, MD,
Chair, Department of Ophthalmology, Lewis Katz School of Medicine at Temple University